Diphenhydramine Hydrochloride Injection
Product Images NDC 0641-6282

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Diphenhydramine Hydrochloride (NDC 0641-6282). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Diphenhydramine Novaplus 1)

FDA Label Image

Logo (Diphenhydramine Novaplus 2)

Logo (Diphenhydramine Novaplus 2)
Not available.*
FDA Label Image

Unit Label (Diphenhydramine Novaplus 3)

Unit Label (Diphenhydramine Novaplus 3)
DiphentydrAMINE HCI Injection, USP is a high potency medication with a concentration of 50 mg/mL. It is intended for intramuscular (IM) or intravenous (IV) use. It is important to protect the medication from light. The lot number is not available.*
FDA Label Image

Carton Label (Diphenhydramine Novaplus 4)

Carton Label (Diphenhydramine Novaplus 4)
Not available.*
FDA Label Image

Serialization Image (Diphenhydramine Novaplus 5)

Serialization Image (Diphenhydramine Novaplus 5)
The text provided appears to be a product label or identification information. It includes a GTIN (Global Trade Item Number), a serial number (SN), an expiration date (EXP), and a lot number (LOT). However, the specific details and readable content cannot be determined from the text provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.